POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $85,394 | +22.0% | 35,880 | +129.7% | 0.00% | – |
Q1 2022 | $70,000 | -41.2% | 15,619 | -10.6% | 0.00% | – |
Q4 2021 | $119,000 | -1.7% | 17,477 | +5.6% | 0.00% | – |
Q3 2021 | $121,000 | -29.2% | 16,543 | -3.1% | 0.00% | – |
Q2 2021 | $171,000 | -18.6% | 17,075 | -22.3% | 0.00% | – |
Q1 2021 | $210,000 | +79.5% | 21,975 | +106.8% | 0.00% | – |
Q4 2020 | $117,000 | +95.0% | 10,628 | +57.9% | 0.00% | – |
Q3 2020 | $60,000 | – | 6,732 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
Atom Investors LP | 156,168 | $371,680 | 0.08% |
Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
RBF Capital, LLC | 70,171 | $167,007 | 0.01% |